Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 28, 2018; 24(4): 519-536
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.519
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.519
Ref. | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting |
Ji et al[76] | NA | NA | NA | NA | NA | NA |
Chan et al[77] | NA | NA | NA | NA | NA | NA |
Hu et al[64] | ? | ? | ? | ? | ? | ? |
Bhattacharjee et al[65] | + | ? | - | ? | ? | ? |
Allaix et al[74] | NA | NA | NA | NA | NA | NA |
Kiran et al[29] | NA | NA | NA | NA | NA | NA |
Yamada et al[66] | NA | NA | NA | NA | NA | NA |
Otchy et al[67] | NA | NA | NA | NA | NA | NA |
Kim et al[75] | NA | NA | NA | NA | NA | NA |
Tahirkheli et al[62] | + | ? | ? | ? | - | - |
Sasaki et al[61] | + | ? | ? | ? | ? | ? |
Bertani et al[45] | + | + | ? | ? | + | + |
Roig et al[68] | NA | NA | NA | NA | NA | NA |
Bretagnol et al[46] | + | + | + | + | - | + |
Pitot et al[69] | NA | NA | NA | NA | NA | NA |
Alcantara Moral et al[47] | + | + | ? | ? | ? | + |
Miron et al[70] | NA | NA | NA | NA | NA | NA |
Pena-Soria et al[48] | + | + | + | + | - | + |
Leiro et al[59] | + | + | ? | ? | ? | + |
Contant et al[40] | + | + | - (2) | - (2) | - | + |
Bretagnol et al[71] | NA | NA | NA | NA | NA | NA |
Jung et al[49] | + | + | + | + | - | ? |
Veenhof et al[72] | NA | NA | NA | NA | NA | NA |
Ali et al[63] | ? | ? | ? | ? | ? | ? |
Jung et al[50] | + | + | + | + | - | ? |
Platell et al[51] | + | + | + | + | - | - |
Fa-Si-Oen et al[52] | + | + | ? | ? | + | + |
Bucher et al[53] | + | + | + | + | + | + |
Ram et al[54] | + | - (1) | ? | ? | ? | + |
Zmora et al[37] | + | + | ? | ? | - | + |
Young Tabusso et al[55] | ? | ? | - (2) | - (2) | ? | ? |
Miettinen et al[56] | + | + | ? | ? | + | + |
Memon et al[73] | NA | NA | NA | NA | NA | NA |
Fillmann et al[60] | + | + | + | + | + | + |
Burke et al[57] | ? | ? | + | + | - | - |
Brownson et al[58] | ? | ? | ? | ? | ? | ? |
Ref. | Yearpublished | Study methodology | Study numbers | Male: Female gender | Indication for surgery | Location | Primary anastomosis | Laparoscopic approach | |||
MBP, n | No MBP, n | MBP | No MBP | MBP, n | No MBP, n | ||||||
Ji et al[76] | 2017 | Observational | 538 | 831 | Unknown | Unknown | Cancer | Rectum | Y | Unknown | Unknown |
Chan et al[77] | 2016 | Observational | 159 | 97 | 85:74 | 55:42 | Cancer | Colon and rectum | Y | 159 | 97 |
Hu et al[64] | 2017 | RCT | 76 | 72 | Unknown | Unknown | Cancer | Colon and rectum | Y | Unknown | Unknown |
Bhattacharjee et al[65] | 2015 | RCT | 38 | 33 | 21:17 | 20:13 | Cancer, inflammatory bowel disease, volvulus, tuberculosis | Colon and rectum | Y | 0 | 0 |
Allaix et al[74] | 2015 | Observational | 706 | 829 | 361:345 | 432:397 | Cancer, adenoma, diverticulitis, reversal of Hartmann’s procedure, rectal prolapse | Colon and rectum | Y | 829 | 706 |
Kiran et al[29] | 2015 | Observational | 6146 | 2296 | 3030:3116 | 1111:1185 | Unknown | Colon and rectum | N | 4443 | 1389 |
Yamada et al[66] | 2014 | Observational | 152 | 106 | 92:60 | 65:41 | Cancer | Colon only | Y | 97 | 64 |
Otchy et al[67] | 2014 | Observational | 86 | 79 | 39:47 | 39:40 | Cancer, diverticular disease, IBD, rectal prolapse, ischemic colitis, volvulus, colovaginal fistula | Colon and rectum | Y | 37 | 48 |
Kim et al[75] | 2014 | Observational | 1363 | 1112 | 502:694 | 669:610 | Unknown | Colon and rectum | Y | 709 | 472 |
Tahirkheli et al[62] | 2013 | RCT | 48 | 48 | 28:20 | 24:24 | Cancer, diverticular disease, IBD, ischemic colitis | Colon and rectum | Y | unknown | unknown |
Sasaki et al[61] | 2012 | RCT | 38 | 41 | 17:21 | 24:17 | Cancer | Colon only | Y | 29 | 19 |
Bertani et al[45] | 2011 | RCT | 114 | 115 | 65:49 | 60:55 | Cancer | Colon and rectum | Y | 55 | 51 |
Roig et al[68] | 2010 | Observational | 39 | 69 | Unknown | Unknown | Cancer, diverticular disease, IBD, FAP | Colon and rectum | Y | 12 | 20 |
Bretagnol et al[46] | 2010 | RCT | 89 | 89 | 56:33 | 46:43 | Rectal cancer | Rectum only | Y | 73 | 74 |
Pitot et al[69] | 2009 | Observational | 59 | 127 | 31:28 | 53:74 | Cancer, diverticular disease, IBD | Colon only | Y | 26 | 30 |
Alcantara Moral et al[47] | 2009 | RCT | 70 | 69 | 41:28 | 48:22 | Cancer | Left colon and rectum | Y | 12 | 15 |
Miron et al[70] | 2008 | Observational | 60 | 39 | Unknown | Unknown | Unknown | Colon and rectum | Y | Unknown | Unknown |
Pena-Soria et al[48] | 2008 | RCT | 65 | 64 | 35:29:00 | 33:22 | Cancer, IBD | Colon and rectum | Y | Unknown | Unknown |
Leiro et al[59] | 2008 | RCT | 64 | 65 | 39:25 | 38:27 | Benign and malignant colorectal pathology | Colon and rectum | N | Unknown | Unknown |
Contant et al[40] | 2007 | RCT | 670 | 684 | 337:333 | 345:339 | Cancer, IBD | Colon and rectum | Y | None | None |
Bretagnol et al[71] | 2007 | Observational | 61 | 52 | 42:19 | 32:20 | Rectal cancer | Rectum only | Y | Unknown | 27 |
Jung et al[49] | 2007 | RCT | 686 | 657 | 306:380 | 317:340 | Cancers, diverticular disease, adenoma | Colon only | Y | None | None |
Veenhof et al[72] | 2007 | Observational | 78 | 71 | 28:43 | 33:45 | Not specified | Colon and rectum | Y | Unknown | Unknown |
Ali et al[63] | 2007 | RCT | 109 | 101 | Unknown | Unknown | Unknown | Colon and rectum | Y | Unknown | Unknown |
Jung et al[50] | 2006 | RCT | 27 | 17 | Unknown | Unknown | Cancer, adenoma and diverticular disease | Rectum only | Y | None | None |
Platell et al[51] | 2006 | RCT | 147 | 147 | Unknown | Unknown | Cancer, IBD, diverticular disease, adenoma | Colon and rectum | N | Unknown | Unknown |
Fa-Si-Oen et al[52] | 2005 | RCT | 125 | 125 | 58:67 | 56:69 | Cancer, diverticular disease | Colon only | Y | None | None |
Bucher et al[53] | 2005 | RCT | 78 | 75 | 47:31 | 34:41 | Cancer, diverticular disease, reversal of Hartmann’s procedure, adenoma, endometriosis | Left colon and rectum | Y | 20 | 22 |
Ram et al[54] | 2005 | RCT | 164 | 165 | 99:65 | 102:63 | Cancer, diverticular disease, IBD | Colon and rectum | Y | Unknown | Unknown |
Zmora et al[37] | 2003 | RCT | 187 | 193 | 103:84 | 94:99 | Cancer, diverticular disease, IBD | Colon and rectum | Y | Unknown | Unknown |
Young Tabusso et al[55] | 2002 | RCT | 24 | 23 | 12:12 | 9:14 | Unknown | Colon and rectum | Y | Unknown | Unknown |
Miettinen et al[56] | 2000 | RCT | 138 | 129 | 68:70 | 62:67 | Cancer, IBD, diverticular disease | Colon and rectum | 91% primary anastomosis in both arms | None | None |
Memon et al[73] | 1997 | Observational | 61 | 75 | 32:29 | 44:31 | Cancer, diverticular disease, IBD, adenoma, lipoma | Left colon and rectum | Y | Unknown | Unknown |
Fillmann et al[60] | 1995 | RCT | 30 | 30 | Unknown | Unknown | Cancer, diverticular disease, IBD, ischemic colitis | Colon and rectum | N | Unknown | Unknown |
Burke et al[57] | 1994 | RCT | 82 | 87 | 52:30 | 43:44 | Cancer, diverticular disease, IBD | Left colon and rectum | Y | Unknown | Unknown |
Brownson et al[58] | 1992 | RCT | 86 | 93 | Unknown | Unknown | Cancer and other | Colon and rectum | Y | Unknown | Unknown |
Ref. | Details of MBP | Details of no MBP | Antibiotics given |
Allaix et al[74] | PEG | Enema before left sided operations | As per local policy |
Kiran et al[29] | As per local policy | Unclear | As per local policy |
Yamada et al[66] | PEG | Glycerin Enema | Flomoxef at induction and 3 hourly intra op |
Otchy et al[67] | PEG | Colonic resections- no MBP | Ertapenem 1 g or levofloxacin/metronidazole 500 mg 1 h post op then continued for 24 h post op |
Rectal resections- single enema | |||
Kim et al[75] | As per local policy | Unclear | As per local policy |
Tahirkheli et al[62] | Saline | No preparation | Oral ciprofloxacin plus unspecified intravenous antibiotics for 24 h post op |
Sasaki et al[61] | PEG and sodium picosulphate | No preparation | Antibiotic regime not specified |
Bertani et al[45] | PEG and a single enema | Single enema only | Cefotixin given at induction, 4, 12 and 24 h. Ceftriaxone and metronidazole given for 5 d post op if heavy contamination |
Roig et al[68] | Mono and di sodium phosphate | No prep | Antibiotic regime not specified |
Bretagnol et al[46] | Senna plus povidone-iodine enema | No prep | ceftriaxone and metronidazole at induction and every 2 hours intra op |
Pitot et al[69] | PEG | Rectal resections had single enema | Antibiotic regime not specified |
Alcantara Moral et al[47] | Sodium phosphate or PEG | Two preoperative enemas | Neomycin and metronidazole 1 d pre op, ceftriaxone and metronidazole at induction |
Miron et al[70] | PEG and sodium sulphate | No preparation | Antibiotic regime not specified |
Pena-Soria et al[48] | PEG and standard enema | No preparation | Gentamicin and metronidazole 30 min pre op and 8 hourly post op |
Leiro et al[59] | Sodium di or monobasic phosphate or PEG | No preparation | Ciprofloxacin and metronidazole 500 mg pre op |
Contant et al[40] | PEG and bisocodyl/ sodium phosphate | No preparation | Antibiotic regime not specified |
Bretagnol et al[71] | Senna plus povidone-iodine enema | No preparation | Ceftriaxone and metronidazole at induction and every 2 h intra op |
Jung et al[49] | As per local policy | No preparation | Trimethoprim + metronidazole or cef and met or dozy and met |
Veenhof et al[72] | PEG | Single enema | Antibiotic regime not specified |
Ali et al[63] | Saline | No preparation | Antibiotic regime not specified |
Jung et al[50] | PEG or sodium phosphate | No preparation | Oral sulphamethoxazole-trimethoprim and metronidazole, cephalsporin and metronidazole, doxycycline and metronidazole |
Platell et al[51] | PEG | Phosphate enema | Timentin or gentamycin and metronidazole at induction |
Fa-Si-Oen et al[52] | PEG | No preparation | Ceftriaxone and metronidazole or gentamycin and metronidazole at induction |
Bucher et al[53] | PEG | Rectal resections had single saline enema | Ceftriaxone and metronidazole at induction and 24 h post op |
Ram et al[54] | Monobasic and dibasic sodium phosphate | No preparation | Ceftriaxone and metronidazole 1 h pre op and 48 post op |
Zmora et al[37] | PEG | Rectal resections had a single phosphate enema | Erythromycin and neomycin for 3 doses and then for 24 h |
Young Tabusso et al[55] | PEG or saline/mannitol | No preparation | Antibiotic regime not specified |
Miettinen et al[56] | PEG | No preparation | Ceftriaxone and metronidazole at induction |
Memon et al[73] | Phosphate enema, picolax, PEG, saline lavage | No preparation | Antibiotic regime not specified |
Fillmann et al[60] | Mannitol | No preparation | Metronidazole and gentamicin 1 h pre op then for 48 h |
Burke et al[57] | sodium picosulphate | No preparation | Ceftriaxone 1 g, metronidazole at induction and 8 and 16 h |
Brownson et al[58] | PEG | No preparation | Antibiotic regime not specified |
Number of participants (MBP vs No MBP) | Odds ratio (95%CI), MBP vs No MBP | P value | |
Anastomotic leak | 2351 (1042 vs 1309) | 0.86 (0.64 to 1.15) | 0.30 |
Surgical site infection | 965 (513 vs 452) | 1.22 (0.82 to 1.81) | 0.33 |
Intra-abdominal collection | 921 (486 vs 435) | 0.54 (0.21 to 1.38) | 0.20 |
Mortality | 813 (419 vs 394) | 0.73 (0.29 to 1.82) | 0.50 |
Re-operation | 1660 (688 vs 392) | 1.57 (1.02 to 2.43) | 0.04 |
- Citation: Rollins KE, Javanmard-Emamghissi H, Lobo DN. Impact of mechanical bowel preparation in elective colorectal surgery: A meta-analysis. World J Gastroenterol 2018; 24(4): 519-536
- URL: https://www.wjgnet.com/1007-9327/full/v24/i4/519.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i4.519